The Sherwin-Williams Company (SHW)

Q2 2026 Earnings Preview

Earnings Date: July 28, 2026 | Prepared: July 27, 2026 | Reporting Period: Q2 2026 (quarter ended June 30, 2026)

2. KPIs & Consensus Expectations

Key Takeaway: Consensus is a modestly low bar on revenue and EPS following post-Q1 downward drift, but PSG same-store sales growth (~2.7% consensus) is the higher-stakes swing factor — a miss there would likely overshadow any EPS beat.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Q1 2026 Actual (Last Quarter)

Q2 2025 Actual (Prior Year)

Q2 2026 Consensus Estimate

YoY Change

Q2 2026 Guidance

Consensus vs. Guidance

Total Revenue ($B)

$5.667B

$6.315B

$6.592B

+4.4% YoY

Up mid-single digit % vs. Q2 2025

~+4.4% vs. prior year; within guidance range

Adj. Diluted EPS ($)

$2.35

$3.38

$3.52

+4.1% YoY

FY $11.50–$11.90 (no Q2-specific EPS guide)

N/A (no Q2 EPS guide)

PSG Same-Store Sales Growth (%)

+2.4%

+0.8%

+2.66%

+186 bps YoY

Low single-digit % (FY)

Within guidance range

PSG Segment Margin (Operating, %)

18.3%

24.8%

24.6%

-20 bps YoY

No explicit Q2 segment margin guide

N/A

Adj. EBITDA ($B)

$0.998B

$1.320B

$1.381B

+4.6% YoY

No explicit Q2 EBITDA guide

N/A

Sources: Visible Alpha Consensus and Actuals Data (Total Revenue, Adj. EPS, PSG SSS, PSG Margin, Adj. EBITDA); SHW Q1 2026 Earnings Release (guidance language).

Table 2 — Beat/Miss History (Last 8 Quarters)

Top KPI 1: Adjusted Diluted EPS

Quarter

Reported ($)

Consensus ($)

Surprise %

Result

Q1 2026

$2.35

$2.25

+4.4%

Beat

Q4 2025

$2.23

$2.16

+3.2%

Beat

Q3 2025

$3.59

$3.45

+4.1%

Beat

Q2 2025

$3.38

$3.82

-11.5%

Miss

Q1 2025

$2.25

$2.16

+4.2%

Beat

Q4 2024

$2.09

$2.04

+2.5%

Beat

Q3 2024

$3.37

$3.56

-5.3%

Miss

Q2 2024

N/A — not in VA for this period

N/A

N/A

N/A

Top KPI 2: PSG Same-Store Sales Growth (%)

Quarter

Reported (%)

Consensus (%)

Surprise (bps)

Result

Q1 2026

+2.4%

+1.8%

+60 bps

Beat

Q4 2025

+1.0%

+2.7%

-170 bps

Miss

Q3 2025

+3.6%

+1.6%

+200 bps

Beat

Q2 2025

+0.8%

+2.1%

-130 bps

Miss

Q1 2025

+1.2%

+2.0%

-80 bps

Miss

Q4 2024

+2.0%

+3.0%

-100 bps

Miss

Q3 2024

+2.2%

+4.3%

-210 bps

Miss

Q2 2024

N/A

N/A

N/A

N/A

Pattern: SHW has beaten on adjusted EPS in 5 of the last 7 reported quarters, but PSG same-store sales have missed consensus in 5 of the last 7 quarters — the Street consistently overestimates volume recovery, making SSS the higher-risk line item heading into Q2. Source: Visible Alpha Consensus and Actuals Data.

3. Guidance & Commentary Evolution

Key Takeaway: Guidance is unchanged since Q1 earnings — full-year adjusted EPS of $11.50–$11.90 was reaffirmed — but the composition has shifted materially: more price, less volume, and higher raw material inflation. Management tone is cautious but confident in execution.

Metric

Initial Guidance (Q1 2026 Earnings Call, Apr 28)

Revised Guidance

Current Consensus

Note

FY 2026 Adj. Diluted EPS

$11.50–$11.90

$11.75 (midpoint)

Reaffirmed at Q1 print; no post-earnings revision. Consensus sits at midpoint.

FY 2026 Consolidated Revenue

Up low-to-mid single digit % vs. 2025

$24.73B (+3.5% YoY)

Unchanged. Consensus within guidance range.

Q2 2026 Consolidated Revenue

Up mid-single digit % vs. Q2 2025

$6.59B (+4.4% YoY)

Consensus at low end of mid-single digit range; slight risk of upside if pricing holds.

FY 2026 Raw Material Inflation

Up low-to-mid single digits (raised from low single digits at Q1)

N/A (not directly modeled by consensus)

↑ Raised at Q1 earnings (Apr 28); heavier weighting in H2. Middle East conflict driving propylene/petrochemical inflation.

FY 2026 Consolidated Price/Mix

High end of low single-digit range (raised from low single digits at Q1)

N/A

↑ Raised at Q1 earnings; now embeds >2x the pricing vs. original January guide. Surgical approach by geography/end market.

FY 2026 Volume

Low single-digit decline (revised down from low single-digit growth at Q1)

N/A

↓ Lowered at Q1 earnings; management expects demand headwinds from Middle East conflict and soft end markets to persist.

FY 2026 SG&A

Up low single-digit %

N/A

Unchanged. Management accelerating cost-reduction actions to offset inflation.

New Store Openings (FY 2026)

80–100 net new stores

N/A

Unchanged. 21 opened, 27 closed in Q1 (net -6); pace expected to accelerate.

Source: SHW Q1 2026 Earnings Release and Earnings Call Transcript (April 28, 2026); Visible Alpha Consensus Data.

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have drifted modestly lower since Q1 earnings for both Q2 and FY 2026, but the magnitude is small — the Street is essentially tracking guidance rather than diverging from it. The gap between consensus and guidance midpoints is narrow, suggesting limited cushion but also limited downside risk from estimate cuts alone.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (May 5, 2026)

Current Consensus (Jul 27, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

Total Revenue — Q2 2026

$6.605B

$6.592B

-0.2%

Up mid-single digit % vs. Q2 2025 (~$6.47B–$6.63B implied)

Unchanged

~+4.4% vs. prior year; at low end of mid-single digit range

Adj. Diluted EPS — Q2 2026

$3.507

$3.523

+0.5%

No Q2-specific EPS guide

No Q2-specific EPS guide

N/A

PSG SSS — Q2 2026

+3.00%

+2.66%

-34 bps

Low single-digit % (FY)

Unchanged

Within guidance range

Total Revenue — FY 2026

$24.758B

$24.727B

-0.1%

Up low-to-mid single digit % vs. 2025

Unchanged

~+3.5% YoY; within guidance range

Adj. Diluted EPS — FY 2026

$11.698

$11.747

+0.4%

$11.50–$11.90

$11.50–$11.90 (reaffirmed)

+0.4% above midpoint ($11.70)

Adj. EBITDA — Q2 2026

$1.374B

$1.381B

+0.5%

No Q2-specific EBITDA guide

No Q2-specific EBITDA guide

N/A

Estimates have been remarkably stable since Q1 earnings, with Q2 revenue and EPS essentially flat to slightly up versus the post-print baseline. The modest downward drift in PSG SSS consensus (-34 bps) reflects the Street's continued skepticism about volume recovery, consistent with the historical pattern of SSS misses. FY 2026 EPS consensus sits just above the guidance midpoint, implying the Street believes SHW can execute on its pricing-led strategy but is not pricing in meaningful upside.

Source: Visible Alpha Consensus and Actuals Data (as-of dates: May 5, 2026 and July 27, 2026); SHW Q1 2026 Earnings Call Transcript.

5. Stock Performance

Key Takeaway: SHW has underperformed both XLB and the S&P 500 since Q1 earnings, driven almost entirely by multiple compression rather than estimate cuts — the EV/EBITDA multiple has contracted ~6.5% over 3 months, suggesting the market is discounting the durability of the pricing-led margin story in a soft-volume environment.

SHW vs. XLB (Materials ETF) vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings (April 28, 2026). Source: Yahoo Finance / Stock Price Data.

Since Q1 2026 earnings on April 28, SHW has declined approximately 1% (from $324.27 to ~$327 as of July 28), while the S&P 500 has gained roughly 3.9% and XLB (Materials ETF) has been essentially flat. The underperformance is attributable almost entirely to multiple compression: the NTM EV/EBITDA multiple has contracted from ~19.5x to ~18.3x over the past 3 months (-6.5%), and the NTM P/E has compressed from ~27.8x to ~25.2x (-9.6%). This is not an estimate-driven selloff — consensus EPS has been essentially flat — but rather a re-rating of the premium the market is willing to pay for SHW's growth story in a prolonged soft-demand environment. The stock found a trough in early June (~$293) before recovering sharply through late June and early July (reaching $352 on July 2), then pulling back again into earnings. The late-June rally appears to have been driven by improving sentiment around the housing market and a broader materials sector rotation, not company-specific catalysts. At current levels, SHW trades at ~25x NTM P/E versus a peer average in the low-to-mid 20s, still commanding a premium but at the lower end of its recent historical range.

Source: Yahoo Finance / Stock Price Data; Visible Alpha (NTM multiples).

6. Material News & Developments

Key Takeaway: The most material development since Q1 earnings is the escalation of Middle East conflict-driven petrochemical inflation, which has forced SHW to implement surgical mid-season price increases — the key question for Q2 is whether those increases are sticking without sacrificing volume.

7. Peer Commentaries / Read-Throughs (Last 60 Days)

Key Takeaway: Peer commentary from Dow (Q2 2026 results) and RPM International (Q4 FY2026 results, covering March–May 2026) provides the most relevant same-quarter read-throughs for SHW's Q2 2026. Both confirm: (1) architectural coatings demand was positive in Q2, (2) raw material inflation is real and accelerating, and (3) pricing power is holding but volume is mixed. RPM's forward commentary about DIY stabilization is a cautious positive for SHW's Consumer Brands Group.

Methodology Note: Only commentary based on conditions during SHW's Q2 2026 (April–June 2026) or an overlapping period is included as a direct read-through. Forward-looking guidance from peers about their own future quarters is labeled as context only and not treated as a Q2 2026 read-through.

Dow Inc. (DOW) — Q2 2026 Earnings (Reported July 23, 2026)

Coverage Period: April–June 2026 (exact same quarter as SHW Q2 2026). Relevance: High — Dow is a major supplier of petrochemical raw materials and a participant in the architectural coatings value chain.

RPM International (RPM) — Q4 FY2026 Earnings (Reported July 22, 2026)

Coverage Period: March 1 – May 31, 2026 (RPM's fiscal Q4). Overlap with SHW Q2 2026: April and May 2026 (2 of 3 months). Relevance: High — RPM is a direct coatings peer with significant exposure to professional, industrial, and consumer paint markets.

Peer Read-Through Summary Table

Theme

Peer Signal

Source

SHW Implication

Architectural Coatings Demand

Positive — price and volume both up YoY in Q2

DOW Q2 2026

Supports PSG and PCG revenue beat potential

U.S. Housing / DIY

Negative — housing soft, DIY markets challenging

DOW Q2 2026; RPM Q4 FY2026

Headwind for CBG North America and new residential PSG

Raw Material Inflation

Negative — petrochemical inflation elevated; propylene oxide supply tight

DOW Q2 2026; RPM Q4 FY2026

Validates SHW's raised inflation outlook; gross margin pressure in Q2

Pricing Power

Positive — pricing holding; price/cost slightly favorable

RPM Q4 FY2026; DOW Q2 2026

Supports SHW's surgical pricing strategy; price/mix likely positive in Q2

Industrial / Commercial Demand

Mixed — infrastructure/data center strong; commercial construction weak

RPM Q4 FY2026; DOW Q2 2026

PCG protective & marine and packaging likely strong; general industrial mixed

Margin Expansion

Positive — record margins achievable despite inflation via volume leverage and pricing

RPM Q4 FY2026

Supports SHW's 14-of-15-quarter gross margin expansion track record continuing in Q2

Sources: DOW Q2 2026 Earnings Release and Earnings Call Transcript (July 23, 2026); RPM International Q4 FY2026 Earnings Release and Earnings Call Transcript (July 22, 2026).

8. Insider Transaction Activity

Key Takeaway: No open-market insider purchases or discretionary sales were identified in the SEC Form 4 database for SHW in the 60 days prior to Q2 2026 earnings. The absence of insider buying ahead of earnings is neutral — not a negative signal given the typical quiet period restrictions, but also not a positive catalyst.

Name

Title

Transaction Type

Value

Date

Note

No reportable open-market transactions identified

No Form 4 open-market buys (code P) or discretionary sales (code S) found in the 60-day pre-earnings window. Typical pre-earnings quiet period in effect.

Source: SEC EDGAR Form 4 filings database (search conducted for SHW, May 27 – July 27, 2026).

9. Key Risks